Skip to content

Observation of the Analgesic Effect of Long-acting Local Anesthetics in Postoperative Fracture Patients

Observation of the Analgesic Effect of Long-acting Local Anesthetics in Postoperative Fracture Patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105820
Enrollment
Unknown
Registered
2025-07-11
Start date
2026-01-03
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The breaking of a bone.

Interventions

control group:Exparel? | Dilute 266mg (20ml) to 40ml, and layer by layer infiltrate each level of tissue at the incision site.
Observation group:Exparel | Dilute 266mg (20ml) to 40ml for popliteal nerve block.

Sponsors

Zhenxiong County People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Consent for implementing this research plan: Age: 18-85 years old; Surgical type: Single-side closed lower limb fracture limited open reduction and internal fixation (metatarsal bone/tibial malleolus/tibia); ASA classification: Grade I-III

Exclusion criteria

Exclusion criteria: Refusal to implement this research plan due to: open fractures or combined neurovascular injuries, history of allergy to amide local anesthetics, abnormal liver function (ALT/AST > 2 times the upper limit), long-term use of opioids (>30 mg morphine equivalent per day), cognitive impairment or communication disorders, and severe internal medical conditions such as respiratory and circulatory diseases.

Design outcomes

Primary

MeasureTime frame
The peak VAS score (0-10 points) during active movement of the affected limb within 72 hours post-operation.;

Secondary

MeasureTime frame
Opioid consumption;First time of getting out of bed activity;

Countries

China

Contacts

Public ContactHu Xiuhong

Zhenxiong County People's Hospital

huxiuhongsky@126.com+86 151 2539 4021

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026